Jul 9 2012
OrSense Ltd., developer of monitors for non-invasive measurements of
various blood parameters, introduced today at the 32nd
International Congress of the International Society of Blood Transfusion
(ISBT), in Cancun, Mexico, GlasswingTM, its
next-generation, wireless, non-invasive hemoglobin (Hb) measurement
system for anemia monitoring, hemorrhage detection and pre-donation
screening.
Hemoglobin (Hb) measurements allow the detection of anemia and
hemorrhage, and are widely used in hospital wards such as operation
rooms, ICU, ER and delivery rooms. In blood donation centers, a
pre-donation Hb measurement of blood donors is required by most
countries to protect anemic donors, and to ensure adequate Hb content of
blood units. The determination of Hb levels of prospective blood donors
is usually performed using capillary blood obtained by finger pricking,
rendering current Hb screening methods invasive, painful, time consuming
and labor intensive.
Glasswing, OrSense's next-generation, wireless device offers a unique,
breakthrough non-invasive solution for accurate continuous and spot Hb
measurements. The new portable, wireless system enables on-line storage
and download of data, real-time communication with electronic medical
records in the hospital or blood donation centers as well as with other
digital data devices and printers. The device is well suited for use in
a variety of clinical environments, including perioperative and critical
care, emergency medicine, blood donation facilities, women's health,
primary care physician's office and homecare.
"We are proud to introduce Glasswing, our improved revolutionary
solution for non-invasive measurements of hemoglobin," said Lior D.
Ma'ayan, CEO of OrSense. "OrSense's non-invasive solution
improves anemia screening and monitoring by eliminating pain, reducing
infection risk and enabling a simple and fast diagnosis. Hemoglobin
measurements obtained by our system in multiple applications, showed
accurate performance compared with the gold standard invasive reference
values. Our non-invasive system was found to be environmentally
friendly, safe, fast and easy to use by the operating staff, and is
already in use in multiple blood donation centers and blood banks in
around the world, improving donor and patient safety and care."
In addition, 2 poster presentations will be presented at ISBT, with
results of clinical trials showing that Hb measurements obtained with
OrSense's systems showed accurate performance compared with invasive
point of care (POC) devices. Dr. M. Gavalaki of the Blood Transfusion
Center at Laiko General Hospital, Athens, Greece will present a poster
titled Evaluation of non-invasive pre-donation hemoglobin screening;
and Aharon Weinstein, Vice President of Research at OrSense will present
a poster titled Non-invasive hemoglobin sensor performance in anemia
screening.
Source: OrSense Ltd.
Just five minutes of activity a day could reduce blood pressure